Leong Justin
- SEC CIK
- 0001825782
No open-market purchases or sales filed in the past year.
Current role at each company
- RMD Resmed IncChief Product Officeras of Nov 24, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Leong Justin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Leong JustinChief Product Officer | SSaleReMed Common Stock | −6.16K | $243.09 | −$1.50M | −22.1%21.7K after | |
| Aug 6, 2024 (view filing) | Aug 5 | 1 day | Leong JustinPresident, Asia Latin America | SSaleReMed Common Stock | −48.0K | $217.07 | −$10.4M | −71.9%18.7K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Leong JustinPresident, Asia Latin America | SSaleReMed Common Stock | −3.78K | $229.50 | −$866.8K | −5.9%59.8K after |